Note: Ingredients listed on restricted chemical lists
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
67.4
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
8.9
EC/CAS
9050-36-6
Name of the chemical
Maltodextrin
Concentration
4.3
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
3.9
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
0.11
EC/CAS
25956-17-6
Name of the chemical
Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate (17); (CI 16035)
Concentration
0.001
EC/CAS
3844-45-9
Name of the chemical
Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl-[(3-sulfophenyl)-methyl]-amino]-phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo, inner salts, disodium salt and its ammonium and aluminium salts (17); (CI 42090)
Concentration
0.0001
General Information
Revision date
2021-12-02
Product name
THERAFLU MAX STRENGTH FLU RELIEF - NIGHTTIME
Product Synonyms
WH-2166-0001
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Serious eye damage/eye irritation Category 2 Sensitization, skin Category 1
Environmental hazards
Hazardous to the aquatic environment, Category 3
Long term hazards
OSHA defined hazards Combustible dust
Signal word
Warning
Hazard statements
May form combustible dust concentrations in air. May cause an allergic skin reaction. Causes serious eye irritation. Harmful to aquatic life with long lasting effects.
Prevention
Prevent dust accumulation to minimize explosion hazard. Keep away from heat/sparks/open flames/hot surfaces. - No smoking. Keep container tightly closed. Ground/bond container and receiving equipment. Avoid breathing dust. Wash thoroughly after handling. Contaminated work clothing must not be allowed out of the workplace. Avoid release to the environment. Wear eye protection/face protection. Wear protective gloves.
Response
If on skin Wash with plenty of water/. If in eyes Rinse cautiously with water for several minutes Remove contact lenses, if present and easy to do. Continue rinsing. Specific treatment (see on this label). If skin irritation or rash occurs Get medical advice/attention. If eye irritation persists Get medical advice/attention. Take off contaminated clothing and wash it before reuse. In case of fire: Use appropriate media to extinguish.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise None known.
Additional information
6.15% of the mixture consists of component(s) of unknown acute oral toxicity. 90.65% of the mixture consists of component(s) of unknown acute dermal toxicity. 90.65% of the mixture consists of component(s) of unknown acute inhalation toxicity. 81.75% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 79.15% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
